Tianqi Xu

机构：Uppsala University, UNSW Sydney, Xijing Hospital, Air Force Medical University · ORCID：0000-0002-1826-4093

发表论文 48 篇 · 总被引 466 次 · h-index 15

代表论文

• Radionuclide Therapy of HER2-Expressing Xenografts Using [177Lu]Lu-ABY-027 Affibody Molecule Alone and in Combination with Trastuzumab (2023 · Cancers · 被引 24)
• Comparison of HER2-targeted affibody conjugates loaded with auristatin- and maytansine-derived drugs (2023 · Journal of Controlled Release · 被引 20)
• Conditionally activated affibody-based prodrug targeting EGFR demonstrates improved tumour selectivity (2023 · Journal of Controlled Release · 被引 16)
• Half-life extension via ABD-fusion leads to higher tumor uptake of an affibody-drug conjugate compared to PAS- and XTENylation. (2024 · Journal of Controlled Release · 被引 13)
• Evaluation of affinity matured Affibody molecules for imaging of the immune checkpoint protein B7-H3 (2023 · Nuclear Medicine and Biology · 被引 11)
• Probiotic potential of Bacillus velezensis MZ-09: Assessing characteristics and safety through in vitro and in vivo analyses (2025 · Microbiological Research · 被引 9)